|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
1998-7-14
|
|
pubmed:abstractText |
The clinical applications of fluorine-18-deoxyglucose Positron Emission Tomography (FDG PET) have been proposed on account of experimental evidence of increased glucose metabolism in tumor cells.
|
|
pubmed:language |
ita
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0033-8362
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
95
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
98-104
|
|
pubmed:dateRevised |
2008-10-21
|
|
pubmed:meshHeading |
pubmed-meshheading:9636735-Female,
pubmed-meshheading:9636735-Fluorodeoxyglucose F18,
pubmed-meshheading:9636735-Follow-Up Studies,
pubmed-meshheading:9636735-Hodgkin Disease,
pubmed-meshheading:9636735-Humans,
pubmed-meshheading:9636735-Lymphoma, Non-Hodgkin,
pubmed-meshheading:9636735-Male,
pubmed-meshheading:9636735-Neoplasm Staging,
pubmed-meshheading:9636735-Radiopharmaceuticals,
pubmed-meshheading:9636735-Tomography, Emission-Computed
|
|
pubmed:articleTitle |
[Positron-emission tomography with fluorine-18-deoxyglucose in the staging and control of patients with lymphoma. Comparison with clinico-radiologic assessment].
|
|
pubmed:affiliation |
Istituto Nazionale dei Tumori, Università degli Studi Federico I, Napoli.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract,
Research Support, Non-U.S. Gov't
|
